Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cue Biopharma Inc (NQ: CUE ) 1.780 +0.130 (+7.88%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cue Biopharma Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session October 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session October 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session October 04, 2024 Via Benzinga Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting October 04, 2024 From Cue Biopharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session October 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session September 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 27, 2024 Via Benzinga Cue Biopharma Announces Pricing of $12.0 Million Public Offering September 26, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Announces Proposed Public Offering September 26, 2024 From Cue Biopharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session September 26, 2024 Via Benzinga Cue Biopharma Announces Proposed Public Offering September 26, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer September 09, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference September 03, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights August 19, 2024 From Cue Biopharma, Inc. Via GlobeNewswire CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q2 2024 August 15, 2024 CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Cue Biopharma to Host Business Update Call and Webcast August 13, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements July 25, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting June 04, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024 June 03, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Medical Moonshots: 3 Biotech Stocks Set to Skyrocket May 30, 2024 Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended. Via InvestorPlace CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Present at the 20th Annual PEGS Boston Summit May 08, 2024 From Cue Biopharma, Inc. Via GlobeNewswire Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference May 07, 2024 From Cue Biopharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Cue Biopharma, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
